Moneyta · stock research · no sign-up needed
BSX
FollowFigures below come straight from SEC filings: every number is the company's own, on the record.
Revenue (Q2 FY2026)
$5.4B
+16.7% y/y
Net income
-
as filed with the SEC
Institutions holding
1,489
-195 last quarter
Overview · BOSTON SCIENTIFIC CORP
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronizatio…
Management team
- Ms. Mary Beth Moynihan · Senior VP of Market Access & Chief Marketing OfficerFind on LinkedIn
- Mr. Vance R. Brown J.D. · Senior VP, General Counsel & Corporate SecretaryFind on LinkedIn
- Ms. Jodi Euerle Eddy · Senior VP and Chief Information & Digital OfficerFind on LinkedIn
- Ms. Emily M. Woodworth · Senior VP, Global Controller & Chief Accounting OfficerFind on LinkedIn
Start free to see the full management team.
Links open LinkedIn searches, not verified profiles. Team data from our market-data vendor's company profile.
What history says when its signals fire
Every signal Moneyta surfaces carries its full base-rate history: how often it beat the index, and how often it didn't. See the evidence
The desk's Snapshot
3 of 15 open to everyone · members see allRead the full desk report on BSX
Seven analysts, the debate, the risk review, every claim cited. And the same for every name you hold.
Free plan, no credit card required. Silver opens the full report, $19.99 a month. AI-written · every claim cites a source · Insight, not advice.
The full desk report
Seven AI analysts read the filings and argue both sides. What survives, with every claim cited, for members.
Who holds it, who's buying Gold
Full holder table, quarter-over-quarter flows, insider transactions, and the conviction screen.
Largest holder
Net flow last quarter
Insider buys, 90d
Further reading
Source: SEC EDGAR (XBRL company facts, form 13F-HR). Educational analysis of published data: insight, not advice.